ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC19531-10mg |
|
1374853-91-4 |
Pembrolizumab
|
0 | — | |
GC19530-10mg |
|
474-67-9 |
Brassicasterol
|
0 | C28H46O | |
GC19530-5mg |
|
474-67-9 |
Brassicasterol
|
0 | C28H46O | |
GC19530-1mg |
|
474-67-9 |
Brassicasterol
|
0 | C28H46O | |
GC19529-100mg |
|
146724-86-9 |
MAHMA NONOate
|
0 | C8H20N4O2 | |
GC19529-50mg |
|
146724-86-9 |
MAHMA NONOate
|
0 | C8H20N4O2 | |
GC19529-25mg |
|
146724-86-9 |
MAHMA NONOate
|
0 | C8H20N4O2 | |
GC19529-10mg |
|
146724-86-9 |
MAHMA NONOate
|
0 | C8H20N4O2 | |
GC19528-500g |
|
106-51-4 |
1,4-Benzoquinone
|
0 | C6H4O2 | |
GC19528-25g |
|
106-51-4 |
1,4-Benzoquinone
|
0 | C6H4O2 | |
GC19527-500g |
|
100-02-7 |
4-Nitrophenol
|
0 | C6H5NO3 | |
GC19527-100g |
|
100-02-7 |
4-Nitrophenol
|
0 | C6H5NO3 | |
GC19527-25g |
|
100-02-7 |
4-Nitrophenol
|
0 | C6H5NO3 | |
GC19526-500ug |
|
2222132-40-1 |
Cyclic di-GMP (sodium salt)
|
0 | C20H22N10O14P2 • 2Na | |
GC19526-1mg |
|
2222132-40-1 |
Cyclic di-GMP (sodium salt)
|
0 | C20H22N10O14P2 • 2Na | |
GC19522-500g |
|
143-19-1 |
Sodium oleate
|
0 | C18H33NaO2 | |
GC19521-25g |
|
408-35-5 |
Sodium Palmitate
|
0 | C16H31NaO2 | |
GC19521-5g |
|
408-35-5 |
Sodium Palmitate
|
0 | C16H31NaO2 | |
GC19520-100mg |
|
921625-62-9 |
Cysteine Protease inhibitor
|
0 | C₁₈H₁₄N₄O | |
GC19520-50mg |
|
921625-62-9 |
Cysteine Protease inhibitor
|
0 | C₁₈H₁₄N₄O | |